Revolution Medicines (FRA:42Z) Institutional Ownership: 48.11% (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:42Z Revolution Medicines Inc FRA:42Z
25 GF Score
Price €179.40
! 3 Warning Signs
View Full Analysis

What is Revolution Medicines Institutional Ownership?

Revolution Medicines FRA:42Z +0.22% 25 Institutional Ownership is 48.11% as of Aug. 12, 2026. GuruFocus rates FRA:42Z with a GF Score™ of 25/100. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Revolution Medicines's institutional ownership is 48.11%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Revolution Medicines's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Revolution Medicines's Float Percentage Of Total Shares Outstanding is 94.70%.

Revolution Medicines Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Revolution Medicines's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revolution Medicines Institutional Ownership Chart

Revolution Medicines Historical Data

The historical data trend for Revolution Medicines can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 52.07 52.03 46.84 44.04 44.68 42.13 41.44 42.33 47.75 48.11
FRA:42Z
25GF Score
Revolution Medicines Inc FRA:42Z
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revolution Medicines Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 48.11% mean?
Revolution Medicines (FRA:42Z) has a Institutional Ownership of 48.11% as of Aug. 12, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Revolution Medicines and its competitors.
Is Revolution Medicines' Institutional Ownership too high?
Revolution Medicines' current Institutional Ownership is 48.11%. Overall, Revolution Medicines has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Revolution Medicines' Institutional Ownership compare to ALNY and ONC?
Revolution Medicines' Institutional Ownership of 48.11% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Revolution Medicines and its competitors. Revolution Medicines's current Institutional Ownership is 48.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revolution Medicines stock overvalued right now?
Revolution Medicines (FRA:42Z) has a current Institutional Ownership of 48.11%. The current Institutional Ownership is 48.11%. Revolution Medicines' overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Revolution Medicines (FRA:42Z), the current Institutional Ownership is 48.11% as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Revolution Medicines Business Description

Address 700 Saginaw Drive, Redwood City, CA, USA, 94063
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
25GF Score

Get the complete analysis for FRA:42Z

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€179.40
Price